eMudhra Q1: consolidated PAT ₹32 Cr, +28% YoY as Cryptas lifts revenue 29%
PAT +27.86% YoY · revenue +29.47% · margins compressing
₹190.72 Cr
+29.47% YoY
₹32 Cr
+27.86% YoY
16.63%
0pp YoY
₹3.91
eMudhra reported consolidated Q1 FY27 revenue of ₹190.7 Cr, up 29.5% YoY from ₹147.3 Cr, with net profit of ₹32.0 Cr, up 27.9% YoY from ₹25.0 Cr — a clean print with no exceptional items on either side. Sequentially revenue slipped 1.4% off a seasonally strong ₹193.4 Cr March quarter, but PAT rose 8.2% QoQ, and basic EPS improved to ₹3.91 from ₹3.05 a year ago. The bulk of the topline lift is inorganic: the international Enterprise-Trust business (which now houses the consolidated Cryptas/European entities) contributed ₹125.5 Cr of the ₹190.7 Cr revenue, and the newly folded-in subsidiaries show up in a 6x jump in finance costs (₹1.2 Cr vs ₹0.2 Cr) and a 78% rise in depreciation (₹12.0 Cr vs ₹6.7 Cr).
Q1 FY-2027 vs prior quarters
That integration cost is where the margin story sits: operating margin compressed to ~20.6% from ~23.5% a year ago (and 21.7% in Q4), even as net margin held roughly flat at ~16.8% (vs 16.6% YoY) — so the squeeze is at the operating line from acquired-business D&A and interest, not at the bottom line. The standalone entity (India parent) grew more modestly — revenue ₹66.1 Cr (+14.4% YoY) and PAT ₹12.4 Cr (+21.3% YoY) — underlining that the consolidated growth is being driven by the overseas/subsidiary stack rather than the core India CA business.
The stock went into the print at ₹454.4, up 3% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 5 consecutive quarters.
What the summary numbers don't show
Results unaudited, limited-review by Suri & Co with unmodified conclusion — approved by board July 29, 2026
Management guides for 15-18% organic revenue growth and 25-30% PAT growth in FY27, driven by an increasing mix of higher-margin product sales. The company is focused on product-led growth fueled by cybersecurity trends like AI and PQC, international expansion, and DPI deployments. Strategically, the company announced a
— This quarter: met
Against management's May guidance of 15-18% organic revenue growth and 25-30% PAT growth for FY27, the ₹32 Cr PAT (+28%) lands squarely inside the profit band, confirming the confident tone from the Q4 concall; the reported +29.5% revenue is flattered by the Cryptas consolidation, so the organic pace needs the July 30 earnings call to verify. No brokerage consensus is published for this small/mid-cap, so the print can't be graded against a formal Street number. The board approved the results on July 29; a dividend record date was set for June 18 earlier in the quarter, and the company picked up ESG scores (SES 68, Crisil ESG 60) during Q1.
W1
Organic vs inorganic revenue split at the July 30 earnings call — is core growth inside the guided 15-18% band ex-Cryptas?
W2
Operating margin trajectory: whether ~20.6% OPM recovers as acquired D&A/finance costs normalise, or stays diluted
W3
PAT run-rate vs the 25-30% FY27 guidance and the stated 3-year PAT-doubling goal after a ₹32 Cr Q1
Source in INR million; converted to Cr (÷10). No exceptional items. Consol PAT 31.997 Cr is after associate loss (−0.018 Cr); owners' share 32.146 Cr, NCI −0.149 Cr. Finance cost (11.96mn vs 2.01mn YoY) and D&A (119.78mn vs 67.26mn) up sharply from Cryptas/subsidiary consolidation.
Informational and educational content only. Not investment advice.